Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History STOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics STOK

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Stoke Therapeutics Inc

STOK
Current price
13.22 USD +0.87 USD (+7.04%)
Last closed 12.35 USD
ISIN US86150R1077
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 721 771 008 USD
Yield for 12 month -12.74 %
1Y
3Y
5Y
10Y
15Y
STOK
21.11.2021 - 28.11.2021

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts. Address: 45 Wiggins Avenue, Bedford, MA, United States, 01730

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

22.38 USD

P/E Ratio

16.12

Dividend Yield

Financials STOK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures STOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+36 555 000 USD

Last Year

+8 780 000 USD

Current Quarter

+158 569 000 USD

Last Quarter

+22 614 000 USD

Current Year

+32 113 000 USD

Last Year

+8 780 000 USD

Current Quarter

+158 569 000 USD

Last Quarter

+21 506 000 USD
EBITDA 40 331 000 USD
Operating Margin TTM 70.15 %
Price to Earnings 16.12
Return On Assets TTM 7.81 %
PEG Ratio
Return On Equity TTM 20.50 %
Wall Street Target Price 22.38 USD
Revenue TTM 190 908 000 USD
Book Value 6.41 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 3 661.10 %
Dividend Yield
Gross Profit TTM 190 908 000 USD
Earnings per share 0.82 USD
Diluted Eps TTM 0.82 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin 26.33 %

Stock Valuation STOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 16.12
Forward PE
Enterprise Value Revenue 1.92
Price Sales TTM 3.78
Enterprise Value EBITDA 9.09
Price Book MRQ 2.06

Technical Indicators STOK

For 52 Weeks

5.35 USD 16.15 USD
50 Day MA 10.86 USD
Shares Short Prior Month 12 107 800
200 Day MA 10.51 USD
Short Ratio 20.21
Shares Short 11 534 286
Short Percent 26.83 %